Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Holly Yu, MSPH
Director, Market Access,
Pfizer Specialty Care Business Unit,
Pfizer Inc,
Collegeville, PA
Director, Market Access, Pfizer Specialty Care Business Unit, Pfizer Inc, Collegeville, PA
Authored Items
The Incidence Rate and Economic Burden of Community-Acquired Pneumonia in a Working-Age Population
Jonah Broulette, ASA, MAAA
,
F. Randy Vogenberg, PhD, FASHP
,
Holly Yu, MSPH
,
Kosuke Iwasaki, FIAJ, MAAA
,
Reiko Sato, PhD
,
Bruce S. Pyenson, FSA, MAAA
September/October 2013, Vol 6, No 8
in
Practice Management
Last modified: October 23, 2013